← Eichor
Condition: Glioblastoma Isocitric Dehydrogenase Idh Wildtype Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Glioblastoma Isocitric Dehydrogenase Idh Wildtype

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
Phase 2 · 1 location(s) · Northwestern University · NCT05864534Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
Phase N/A · 5 location(s) · Juan M Garcia-Gomez · NCT07111195TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)
NA · 1 location(s) · Prof. Franciszek Lukaszczyk Memorial Oncology Center · NCT07668869Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Phase 1/Phase 2 · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT07416188A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma
Phase 1/Phase 2 · 16 location(s) · Debiopharm International SA · NCT05765812A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
EARLY_Phase 1 · 3 location(s) · Ugonma Chukwueke · NCT06552260Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Phase 1 · 8 location(s) · Orbus Therapeutics, Inc. · NCT05879367A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Phase 1/Phase 2 · 3 location(s) · Myosin Therapeutics Inc. · NCT07185880A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Phase 2/Phase 3 · 63 location(s) · Global Coalition for Adaptive Research · NCT03970447Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT06430424
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.